RFAIUHIGH SIGNALFINANCIAL10-K

RFAIU experienced significant shareholder redemptions that substantially reduced its assets and trust account funds while extending its business combination deadline.

The company faced substantial shareholder redemptions with over 6.6 million shares redeemed for approximately $71.6 million, reducing outstanding shares from 15 million to 8.3 million and leaving only $51.9 million in the trust account. The extension of the business combination deadline from 18 to 27 months suggests the company needed additional time to complete a deal, which combined with the large redemptions indicates investor skepticism about the SPAC's prospects.

Comparing 2026-02-11 vs 2025-03-25View on EDGAR →
FINANCIAL ANALYSIS

The balance sheet reflects the impact of major shareholder redemptions, with total assets declining substantially from $120.1M to $52.7M and current assets falling meaningfully from $984K to $402K. Stockholders equity became more negative, moving from -$3.3M to -$4.6M, while total liabilities increased modestly to $5.0M. The overall financial picture shows a SPAC under pressure, with significantly reduced resources and a shrinking shareholder base as it seeks to complete its initial business combination.

FINANCIAL STATEMENT CHANGES
Current Assets
Balance Sheet
-59.2%
$984K→$402K

Current assets declined 59.2% — monitor working capital adequacy and short-term liquidity.

Total Assets
Balance Sheet
-56.1%
$120.1M→$52.7M

Total assets contracted 56.1% — asset sales, write-downs, or balance sheet optimization underway.

Stockholders Equity
Balance Sheet
-37.7%
-$3.3M→-$4.6M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Total Liabilities
Balance Sheet
+15.6%
$4.3M→$5.0M

Liabilities increased 15.6% — monitor debt-to-equity ratio and interest coverage.

LANGUAGE CHANGES
NEW — 2026-02-11
PRIOR — 2025-03-25
ADDED
FORM 10-K SUMMARY 92 SIGNATURES 93 i CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS The statements contained in this Form 10-K that are not purely historical are forward-looking statements.
In connection with the shareholders vote at the extraordinary general meeting, holders of 6,668,735 ordinary shares of the Company exercised their right to redeem such shares for a pro rata portion of the funds held in the Trust Account.
As a result, approximately $71,580,705 (approximately $10.73 per share) was removed from the Trust Account to pay such holders and approximately $51,857,714 remained in the Trust Account as of the date of the redemption.
Following the aforementioned redemption, the Company has an aggregate 8,343,765 ordinary shares outstanding, of which 4,831,265 are public shares.
We currently have up to 27 months from the closing of the Initial Public Offering to consummate a Business Combination.
+7 more — sign up free →
REMOVED
0 As of March 25, 2025, there were 15,012,500 Ordinary Shares, par value $0.0001 per share, issued and outstanding.
FORM 10-K SUMMARY 89 SIGNATURES 90 i CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS The statements contained in this Form 10-K that are not purely historical are forward-looking statements.
We have up to 18 months from the closing of the Initial Public Offering to consummate a Business Combination.
Redemption of Public Shares and Liquidation if no Initial Business Combination Our Amended and Restated Memorandum and Articles of Association provides that we will have only 18 months from the closing of the Initial Public Offering to complete our Business Combination.
We expect that all costs and expenses associated with implementing our plan of liquidation and dissolution, as well as payments to any creditors, will be funded from amounts remaining out of the approximately $750,000 of proceeds held outside the Trust Account, although we cannot assure you that there will be sufficient funds for such purpose.
+6 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →